Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors

Clinical Interventions in Aging

Volumn 8, Issue , 2013, Pages 573-580

  Castellon, Xavier ^a   Bogdanova, Vera ^a  

^a Department of Cardiology   (France)

Author keywords

Arterial age; FMV; MRI; Radio frequency; RF QAS; RF QIMT; Velocimetry

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; DIABETES MELLITUS; DIAGNOSTIC VALUE; DYSLIPIDEMIA; EARLY DIAGNOSIS; ENDOTHELIAL DYSFUNCTION; HEREDITY; HUMAN; HYPERTENSION; NON INVASIVE PROCEDURE; OBESITY; OXIDATIVE STRESS; PATIENT MONITORING; PULSE WAVE; RELIABILITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCIBILITY; SCREENING TEST; SMOKING; SUBCLINICAL ATHEROSCLEROSIS; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASODILATATION;

ARTERIAL AGE; FMV; MRI; RADIO FREQUENCY; RF QAS; RF QIMT; VELOCIMETRY;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CAROTID INTIMA-MEDIA THICKNESS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; RADIO WAVES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; VASCULAR STIFFNESS; VASODILATION;

EID: 84878347371     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S40150     Document Type: Article

References (95)

1. Mihailidou AS, Ritchie R, Ashton AW (2013). Sex Differences in Sudden Cardiac Death. In: Gaze D, editor. Ischemic Heart Disease. Available from: http://www.intechopen.com/books/ischemic-heart-disease/sex-differences-in-sudden-cardiac-death.
2. Castellon X, Bogdanova V. QIMT by radio frequency (examination of tracking). Method of evaluation thickness of the intimae media among patients having cardio vascular risk factors. Proceedings of Euro Prevent Conference; 2010 May 5-7; Prague, Czech Republic.
3. Castellon X, Bogdanova V. Study of arterial rigidity QAS. Arch Cardiovasc Dis. 2011;3(1):85-86.
4. Sengupta P P, Pedrizzetti G, Kilner PJ, et al. Emerging trends in CV flow visualization. JACC Cardiovasc Imaging. 2012;5(3):305-316.
5. Castellon X, Bogdanova V. Analysis of endothelial function by radio-frequency coupled with two-dimensional echocardiography: the value of fow-mediated vasodilatation. A study of 25 cases. Proceedings of the 4th Conference of SENS, 2009 Sep 3-7 Cambridge, UK.
6. Castellon X, Bogdanova V. Screening protocol of subclinical atherosclerosis with noninvasive imaging methods, by radio frequency (RF) echo 2D. Arch Cardiovasc Dis. 2012;4(1):49.
7. Castellon X, Bogdanova V. Screening protocol of sub clinical atherosclerosis by radio frequency (RF) coupled with 2d echo. Proceedings of the Conference of Evolving Challenges in Promoting Cardiovascular Health; 2011 Nov 4-5; Barcelona, Spain.
8. Castellon X, Bogdanova V. Protocol of screening of sub clinical atherosclerosis by radio frequency (RF) coupled with 2D echo. Proceedings of the 5th: Conference of SENS, 2011 Aug 31-Sep 4; Cambridge, UK.
9. Revkin JH, Shear CL, Pouleur HG, Ryder S W, Orloff DG. Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future. Pharmacol Rev. 2007;59(1):40-53.
10. Charniot JC, Cosson C, Castellon X, et al. Comparison of oxidative stress status in patients with cardiogenic shock due to severe left ventricular dysfunction. Rejuv Res. 2009;12(s1):S17-S59.
11. Shaw LJ, Raggi P, Callister TQ, Berman DS. Prognostic value of coronary artery calcium screening. in asymptomatic smokers and non-smokers. Eur Heart J. 2006;27:968-975.
12. Bampi AB, Rochitte CE, Favarato D, Lemos PA, da Luz PL. Comparison of non-invasive methods for the detection of coronary atherosclerosis. Clinics (Sao Paulo). 2009;64(7):675-682.
13. Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension.1995;25:155-161.
14. Berenson GS, McMahan CA, Voors AW. Cardiovascular Risk Factors In Children: The Early Natural History Of Atherosclerosis And Essential Hypertension. New York, NY: Oxford University Press; 1980.
15. Duenas MR. Tobacco smoke and atherosclerosis progression. JAMA. 1998;280(1):32-33.
16. Haapanen A, Koskenvuo M, Kesäniemi YA, Heikkilä K. Carotid arteriosclerosis in identical twins discordant for cigarette smoking. Circulation. 1989;80:10-16.
17. Richard JL, Ducimetiere P, Cambien F. Tobacco, mortality and morbidity of atherosclerotic cardiovascular diseases - a prospective study in Paris. Bull Schweiz Akad Med Wiss. 1979;35(1-3):51-69. French.
18. Howard G, Wagenknecht LE, Burke GL. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279(2):119-124.
19. Wissler RW, Strong J P. Risk factors and progression of atherosclerosis in youth. PDAY Research Group. Pathological Determinants of Atherosclerosis in Youth. Am J Pathol. 1998;153(4): 1023-1033.
20. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656.
21. Kataoka Y, Shao M, Wolski K, et al. Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus. Eur J Prev Cardiol. Epub January 31, 2012.
22. Nicholls SJ, Tuzcu EM, Crowe T. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravas-cular ultrasound. J Am Coll Cardiol. 2006;16;47(10):1967-1975.
23. Grimbone MA Jr. Vascular endothelium: an integrator of pathophysi-ologic stimuli in atherosclerosis. Am J Cardiol. 1995;75(6 Suppl 1): 67B-70B.
24. Wang SS, Schadt EE, Wang H, et al. Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ Res. 2007;101:e11-e30.
25. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170(2):191-203.
26. Reiner Z, Tedeschi-Reiner E. New information on the pathophysiology of atherosclerosis. Lijec Vjesn. 2001;123(1-2):26-31. Croatian.
27. Cyrus T, Witztum JL, Rader DJ, et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest. 1999;103(11):1597-1604.
28. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006; 47(8s1):C7-C12.
29. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995;91(9):2488-2496.
30. Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet. 2004;5:189-218.
31. Cohen JC, Zannis VI. Genes affecting atherosclerosis. Curr Opin Lipidol. 2001;12(2):93-95.
32. Puddu P, Cravero E, Puddu M, Muscari A. Genes and atherosclerosis: at the origin of the predisposition. Int J Clin Pract. 2005;59(4):462-472.
33. Conlan FM, Folsom AR, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70(3):380-385.
34. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homo-cysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285(19):2481-2485.
35. Kullo IJ, Gau FT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc. 2000;75(4):369-380.
36. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100:96-102.
37. Marmot MG, Rose G, Shipley MJ, Thomas BJ. Alcohol and mortality: a U-shaped curve. Lancet. 1981;1(8220 Pt 1):580-583.
38. Beaudeux JL, Delattre J, Therond P, Bonnefont-Rousselot D, Legrand A, Peynet J. Le stress oxydant, composante physiopathologique de l'athérosclérose [Oxidative stress in the atherosclerotic process.] Immuno-analyse & Biologie Spécialisée. 2006;21(3):144-150.
39. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology. 2006;13(3):129-142.
40. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91(3A): 7A-11A.
41. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R. Atherosclerosis and oxidative stress. Histol Histopathol. 2008;23(3): 381-390.
42. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84(4):1381-1478.
43. Ruiz-Ortega M, Lorenzo O, Rupérez M, et al. Fourth International Seminar on Cardiovascular Biology and Medicine: Part II. Role of the renin-angiotensin system in vascular diseases. expanding the field. Hypertension. 2001;38:1382-1387.
44. Duprez DA. Role of the rennin-angiogenesis-aldosterone system in vascular remodelling and infammation: a clinical review. J Hypertens. 2006;24(6):983-991.
45. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol. 2004;287(2):H435-H446.
46. Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol. 2005;90(4):449-455.
47. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, infammation, and fbrosis. Hypertension. 2001;38:581-587.
48. Castellon X, Bogdanova V. QIMT by radio frequency (examination of tracking) method of evaluation thickness of the intima media among patients having cardio vascular risk factors. Proceedings of the International Conference on Early Disease Detection and Prevention; 2010 Feb 25-28; Munich, Germany.
49. Castellon X, Bogdanova V. QIMT by radio frequency (examination of tracking), method of evaluation thickness of the intima media among patients having cardio vascular risk factors. Clinical implication: about 150 cases. Proceedings of the 4th International Conference on Oxida-tive/Nitrosative Stress and Disease; 2009 Oct 28-30; New York, NY, USA.
50. Castellon X. Methods of assessing endothelial function, vasodilation of interest by the intermediate flow. Cardiology Practice. 2006;8,10-12.
51. Charniot JC, Cosson C, Chemouni F, et al. Oxidative stress implications in cardiogenic shock with ischemic or idiopathic severe left ventricular dysfunction: role of etiologies of cardio-myopathies. Archives of Cardiovascular Diseases Supplements. 2010;2(1):29.
52. Charniot JC, Albertini J P, Cosson C, et al. Mid-term follow up of consecutive patients with cardiogenic shock without acute coronary syndrome. Archives of Cardiovascular Diseases Supplements. 2010;2(1):33.
53. Charniot JC, Vignat N, Albertini J P, et al. Oxidative stress in patients with acute heart failure. Rejuvenation Res. 2008; 11(2):393-398.
54. Calermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111-1115.
55. Widlansky ME, Gokce N, Keaney JF, Vita JA. Les implications cliniques de la dysfonction endothéliale [The clinical implications of endothelial dysfunction]. J Am Coll Cardiol. 2003;42(7):1149-1160.
56. Toth P P. Subclinical atherosclerosis: what it is, what it means and what we can do about it. Int J Clin Pract. 2008;62(8):1246-1254.
57. Shaaban AM, Duerinckx AJ. Wall shear stress and early atherosclerosis. a review. AJR Am J Roentgenol. 2000;174(6):1657-1665.
58. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ, Mowery J. Atherosclerosis. Potential targets for stabilization and regression. Circulation 1992;86(6 Suppl):III117-123.
59. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 2005;85(1):9-23.
60. Robertson MB, Köhler U, Hoskins PR, Marshall I. Quantitative analysis of PC MRI velocity maps: pulsatile fow in cylindrical vessel. Magn Reson Imaging. 2001;19(5):685-695.
61. Kim T, Seo JH, Bang SS, Choi H W, Chang Y, Lee J. Optimisation de la vélocimétrie MR fux de contraste de phase basée sur des mesures et des contraintes de cisaillement [Optimization of MR phase-contrast-based fow velocimetry and shear stress measurements]. Int J Cardiovasc Imaging. 2010;26 Suppl 1:133-142. French.
62. Vanauker MD, Tacy TA, del Nido PJ, Cape EG. Development of a noninvasive marker of wall shear stress effects in discrete subaortic stenosis. Cardiovascular Engineering. 2001;1(3):137-146.
63. Tsou JK, Liu J, Insana M F. Modeling and phantom studies of ultrasonic wall shear rate measurements using coded pulse excitation. IEEE Trans Ultrason Ferroelectr Freq Control. 2006;53(4):724-734.
64. Charniot JC, Cosson X, Castellon V. Comparison of oxidative stress status in patients with cardiogenic shock due to severe left ventricular dysfunction. Proceedings of the 4th Conference of SENS, 2009 Sep 3-7; Cambridge, UK.
65. Charniot JC, Vignat N, Bonnefont-Rousselot D, et al. Oxidative stress implication in acute heart failure. Proceedings of the 3rd Conference of SENS, 2007 Sep 3-7; Cambridge, UK.
66. Castellon X, Bogdanova V, Charniot JC. QIMT by radio frequency (examination of tracking). Method of evaluation thickness of the intima media among patients having cardio vascular risk factors. Proceedings of the 4th Conference of SENS, 2009 Sep 3-7; Cambridge, UK.
67. Zheng HR, Wang J. A new velocimetry algorithm for optimizing ultrasonic PIV imaging method. Proceedings of the International Special Topic Conference on Information Technology and Applications in Biomedicine; 2008 May 30-31; Shenzhen, China.
68. Li JJ, Fang CH. C-reactive protein is not only an infammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses. 2004;62:499-506.
69. Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol. 1998;18:1359-1362.
70. Tsao C W, Preis SR, Peloso GM, et al. Relations of long-term and contemporary lipid levels and lipid genetic risk scores with coronary artery calcium in the framingham heart study. J Am Coll Cardiol. 2012; 60(23):2364-2371.
71. Samelson EJ, Booth SL, Fox CS, et al. Calcium intake is not associated with increased coronary artery calcification: the Framingham Study. Am J Clin Nutr. 2012;96(6):1274-1280.
72. Towfghi A, Markovic D, Ovbiagele B. Utility of Framingham Coronary Heart Disease Risk Score for predicting cardiac risk after stroke. Stroke. 2012;43(11):2942-2947.
73. Sung KC, Kang SM, Cho EJ, Park JB, Wild SH, Byrne CD. Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men. Arterioscler Thromb Vasc Biol. 2012;32(10):2525-2530.
74. Brindle P, Emberson J, Lampe F, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ. 2003;327:1267.
75. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson P W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004;110:380-385.
76. Lakoski SG, Greenland P, Wong ND, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med. 2007;167(22):2437-2442.
77. Abbott RD, Wilson P W, Kannel WB, Castelli W P. High density lipopro-tein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis. 1988;8(3):207-211.
78. Lange RA. Can you predict what happens when EuroSCORE weds biomarker? J Am Coll Cardiol. 2013;61(6):682-684.
79. Franklin SS, Gustin W 4th, Wong ND. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96(1):308-315.
80. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23:75-80.
81. Huck CJ, Bronas UG, Williamson EB, Draheim CC, Duprez DA, Dengel DR. Noninvasive measurements of arterial stiffness: repeatability and interrelationships with endothelial function and arterial morphology measures. Vasc Health Risk Manag. 2007;3(3):343-349.
82. Adji A, O'Rourke M F, Namasivayam M. Arterial stiffness, its assessment, prognostic value, and implications for treatment. Am J Hypertens. 2011;24(1):5-17.
83. Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
84. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. Hypertension. 2002;39:10-15.
85. Meaume S, Benetos A, Henry O F, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects. 70 years of age. Arterioscler Thromb Vasc Biol. 2001;21:2046-2050.
86. Bouhanick B, Chamontin B. Should pulse pressure and day/night variations in blood pressure be seen as independent risk factors requiring correction or simply as markers to be taken into account when evaluating overall vascular risk? Diabetes Metab. 2007;33(5):321-330.
87. Lane HA, Smith JC, Davies JS. Noninvasive assessment of preclinical atherosclerosis. Vasc Health Risk Manag. 2006;2(1):19.30
88. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens Suppl. 1996;14:S147-S157.
89. Gutierrez MA, Higa M, Pilon PE, Rebelo MDS, Lage SG. Quantitative Assessment of Peripheral Arteries in Ultrasound Images. Medical Imaging in Clinical Practice; 2013. Available from: http:// www.intechopen.com/books/medical-imaging-in-clinical-practice/ quantitative-assessment-of-peripheral-arteries-in-ultrasound-images.
90. Libby P, Ridker PM, Maseri A. Clinical cardiology: new frontiers. Infammation and atherosclerosis. Circulation. 2002;105:1135-1143.
91. Nillson PM, Boutouyrie P, Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension. 2009;54:3-10.
92. Cockcroft JR, Wilkinson IB. Arterial stiffness and pulse contour analysis: an age old concept revisited. Clinical Science. 1979;103(4):379-380.
93. Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H. Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens. 2002;15(5):453-458.
94. Mackenzie I, Wilkinson I, Cockcroft J. Assessment of arterial stiffness in clinical practice. QJM, 2002;95(2):67-74.
95. Simon A, Gariepy J, Levenson J. Ultrasonographic study of the arterial walls: application to the detection of preclinical atherosclerosis. Arch Mal Coeur Vaisseaux. 1997;90(2):7-10. French.